Yilmaz, Suzan http://orcid.org/0000-0001-7511-6073
Nyerges, Akos http://orcid.org/0000-0002-1581-490X
van der Oost, John http://orcid.org/0000-0001-5024-1871
Church, George M. http://orcid.org/0000-0003-3535-2076
Claassens, Nico J. http://orcid.org/0000-0003-1593-0377
Funding for this research was provided by:
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (024.003.019, VI.Veni.192.156)
European Molecular Biology Organization (LTF 160-2019, LTF 160-2019)
DOE | Advanced Research Projects Agency - Energy - U.S. Department of Energy | Small Business Innovative Research and Small Business Technology Transfer (DE-FG02-02ER63445)
NSF | National Science Board (2123243)
Article History
Received: 21 July 2021
Accepted: 28 July 2022
First Online: 20 September 2022
Competing interests
: J.v.d.O. is included as inventor on several CRISPR-related patents and is scientific advisor of NTrans Technologies, Scope Biosciences and Hudson River Biotechnology. G.M.C. is a founder of companies in which he has related financial interests: ReadCoor, EnEvolv and 64x Bio. For a complete list of G.M.C.’s financial interests, see also ExternalRef removed. A.N. is an inventor on a patent related to directed evolution with random genomic mutations (DIvERGE) (US patent 10669537B2: Mutagenizing intracellular nucleic acids). The remaining authors declare no competing interests.